Investigation of reported small molecule P2Y6 receptor antagonists

Medicinal Chemistry Research · Published 2026-07-11 · DOI 10.1007/s00044-026-03591-w

Free full text

Authors (6)

Chianna Dane, André D.J. McKenzie, Andrew P. Montgomery, Jonathan Du, Eryn L. Werry, Michael Kassiou

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Dane, C., McKenzie, A., Montgomery, A., et al. (2026). Investigation of reported small molecule P2Y6 receptor antagonists. Medicinal Chemistry Research. https://doi.org/10.1007/s00044-026-03591-w

Related articles

• Small Molecule Insulin Sensitisers: New Leads and Targets for Next-Generation Insulin Sensitising Strategies · Medicinal Chemistry Research · 2026 · Same journal
• Alisols A-C and their acetate derivatives: a review of natural occurrence, pharmacology, semisynthesis, pharmacokinetics, and metabolism · Medicinal Chemistry Research · 2026 · Same journal
• Discovery of 3-(N-phenylsulfamoyl)-l-phenylalanine derivatives as novel and orally available LAT1-selective inhibitors · Medicinal Chemistry Research · 2026 · Same journal
• From lipophilicity windows to decision-grade antibacterial design: the next translational step for coumarin amphiphiles · Medicinal Chemistry Research · 2026 · Same journal
• Inactivation of ornithine aminotransferase by (1R,4S)-4-Amino-3-(trifluoromethyl)cyclopent-2-ene-1-carboxylic acid via a stable quinonoid intermediate · Medicinal Chemistry Research · 2026 · Same journal
• Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights · Medicinal Chemistry Research · 2026 · Same journal
• Synthesis and antihepatoma activity of dimeric 1-O-acetylbritannilactone derivatives · Medicinal Chemistry Research · 2026 · Same journal
• Unrevealing the Role of Flavonoids in Mitigation of Non-Alcoholic Fatty Liver Disease · Medicinal Chemistry Research · 2026 · Same journal
• Development and evaluation of mitochondria-targeted caseinolytic protease (ClpP) agonist chemical probes in in vitro breast cancer models · Medicinal Chemistry Research · 2026 · Same journal
• Development of new coumarin-piperazine-N-phenylacetamid derivatives as potent tyrosinase inhibitors: In vitro and in silico evaluations · Medicinal Chemistry Research · 2026 · Same journal